Lower Respiratory Tract Infections
13
0
0
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.7%
1 terminated out of 13 trials
88.9%
+2.4% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (13)
Lower Respiratory Tract Infections Managed in Primary Care in France
Real-World Effectiveness of Nirsevimab Against RSV-Related and All-Cause Respiratory Tract Infections in Chinese Infants
Correlation Analysis of Xpert Carba-R Detection of Non-colonized CRE in BALF and Rectal Swabs From Patients With LRTI
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Rapid Diagnostic Supporting Antimicrobial Stewardship in Patients With Pneumonia
Pneumococcal Carriage in Patients With Lower Respiratory Tract Infection (LRTI)
Pathogen Identification in Pediatric Hematopoietic Stem Cell Transplant Patients With Suspected Lower Respiratory Tract Infection
Maternal Vitamin D for Acute Respiratory Infections in Infancy
Study Bronchoalveolar Lavage Fluid Driven Pathogenic Diagnosis of Lower Respiratory Tract Infections
Effect of the Consumption of a Fermented Milk on Common Infections in Adults Submitted to Multi-stressor Situation
Lung Sounds as Indicators of Severity and Recovery of Lung Disease
Nutritional Intervention and Respiratory Infections in Older Subjects
Smoking Ban and Paediatric Hospital Admissions for Respiratory Tract Infections in England